Using ketamine to help people with methamphetamine addiction
KETAMINE FOR METHAMPHETAMINE USE DISORDER STUDY (CTN-0132). 09/28/2022 - 08/21/2025. DSC6. 75N95022F00004 (TO4).
This study is looking at whether ketamine can help people who are trying to overcome methamphetamine addiction by reducing cravings and improving their mental health, and it’s designed for those who are struggling with this issue.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | The Emmes Company, LLC NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project ID | NIH-10720987 on NIH RePORTER |
What this research studies
This research investigates the potential of ketamine as a treatment for individuals struggling with methamphetamine use disorder. Participants will receive ketamine infusions in a controlled setting, with the aim of reducing cravings and improving overall mental health. The study will monitor participants' progress over time to assess the effectiveness of this treatment approach. By focusing on substance misuse, the research seeks to provide new therapeutic options for those affected by addiction.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with methamphetamine use disorder who are seeking treatment.
Not a fit: Patients who are not struggling with methamphetamine use disorder or those with contraindications to ketamine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could offer a novel treatment option for individuals with methamphetamine use disorder, potentially leading to improved recovery outcomes.
How similar studies have performed: Previous research has shown promising results for ketamine in treating other substance use disorders, suggesting potential for success in this area as well.
Where this research is happening
Rockville, United States
- The Emmes Company, LLC — Rockville, United States (Active)
Researchers
- Principal investigator: Mccormack, Jennifer — The Emmes Company, LLC
- Study coordinator: Mccormack, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.